Skip to main content

Advertisement

Table 1 Clinical and laboratory data from participants included in the study

From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

Characteristics Patients
1 2 3 4 5 6 7 8 9
Age 61 66 70 80 72 86 62 66 62
Sex F M M M M M M M M
Diagnosis AL Lambda AL Lambda AL Kappa HCM AL Lambda HCM AL Lambda AL Lambda AL Lambda
Biopsy Abdominal Fata Tongue
Lungs
BMb
Kidneys Myocardial BMa Abdominal fat
BMb
GI
BMb
Kidneys
Organs involvementa Heart
Kidney
Larynx/GI
Heart
Kidneys
Heart Kidneys Heart
Troponin I (< 0.1 ng/ml) < 0.1 < 0.1 < 0.1 < 0.1 1.986 < 0.1 < 0.01 < 0.1 0.08
NT-proBNP (< 300 mg/ml) 2.086 8.804 631 3.188 1.804 N/A 330 183 575
Creatinine (0.50–1.2 mg/dl) 0.49 1.6 1.76 1.45 1.66 1.03 0.7 1.8 2.61
Alb/creat ratio (< 30 mg/g) 2.214 1.972 54 N/A N/A N/A N/A N/A N/A
Free Lambda light chain (0.6–2.6 mg/dl) 3.1 16.7 1 N/A 0.3 N/A 2.7 4.3 8.4
Free Kappa light chain (0.3–2.0 mg/dl) 1.5 1.5 1.7 N/A 0.1 N/A 0.4 3.5 9.2
Free K/L ratio (0.3–1.6) 0.4 0.1 1.7 N/A 0.3 N/A 0.1 0.8 1.1
  1. N/A not available
  2. aOrgans involvement was diagnosed by patient 1: myocardium (echo), kidneys (laboratory), laryngeal/GI (clinically); patient 2: myocardium (cardiac MRI), kidneys (laboratory); patient 7: myocardium (echo); and patient 8: kidneys (laboratory)
  3. bBM biopsy was performed and was positive for plasma cells, but negative for Congo-red stain